The investment offers a secure, highly passive income stream with an exceptionally competitive annual base rent of $92,000 ($7,666.66/month), providing an investor with a protected, low-basis entry point. This value is further insulated by a powerful 1.5-mile restrictive covenant, effectively granting the tenant a retail monopoly by preventing the development of competing drugstores on nearby land. Backed by a national pharmacy leader, this property combines the stability of an essential-retail tenant with the long-term upside of a 3% Gross Sales percentage rent clause. With a contractually guaranteed 8.7% rent escalation scheduled for 2035, which increases the monthly rent to $8,333.33, the asset is perfectly positioned to provide both immediate stability and long-term inflationary growth.